Tempo Bioscience
Developing 10,000 human disease models


Tempo Bioscience
Developing 10,000 human disease models
Tempo creates human disease models for:
Spheroid and organoid models
Physiological barrier models
2-D and 3-D cell models
Cytotoxicity and toxicology applications
Lead optimization studies
Multi-cell type models
Gene therapy dosing models
Blood brain barrier models
Tempo’s Library of 22+ iPSC derivative cell types
- Pericytes
- Microglia
- Osteoblasts
- Melanocytes
- Keratinocytes
- Schwann cells
- Motor Neurons
- Sensory neurons
- Cortical neurons
- Neural progenitors
- CD14+ Monocytes
- Hepatic Stellate Cells
- Dopaminergic neurons
- Mesenchymal stem cells
- Phagocytes (Macrophage)
- Endodermal Progenitor Cells
- Astrocytes (type I and type II)
- Hepatocytes (albumin positive)
- Retinal Pigment Epithelial (RPEs)
- Oligodendrocyte Progenitor Cells
- Kidney Proximal Tubule Cells & Podocytes
- Brain Microvascular Endothelial Cells (BMECs)
- Cardiomyocytes (atrial and ventricular; mixture)
Leadership Team
Angela L. Huang PhD
Founder and President
Angela founded Tempo Bioscience, Inc in 2013. She developed, patented, and commercialized Tempo’s core technologies. Together with Tempo’s team, the enabling technologies became available to scientists worldwide. Angela is listed as an inventor on numerous patents -issued and pending- worldwide and has published in journals such as Nature. She received her scientific training from UC Berkeley, UC San Diego, and UC San Francisco.
Robert “Bob” M. Kay PhD
Chief Advisor
Bob is a biotech-pharmaceutical industry veteran, with 25+ years of experience as a research scientist, corporate vice president of research (GenPharm International), and, most recently, former CEO of Origen Therapeutics Inc for 12 years. He is also the Managing Member of Parallax Biotechnology Advisors LLC. Bob is a member of the Tempo Bioscience advisory board.
Christopher Aguilar JD
Corporate General Counsel
Chris has 25+ years of legal experience as a trial lawyer and in-house general counsel. He has worked with a wide range of companies in their legal and business matters. Formerly, Chris was the general counsel of Merriman Curhan Ford & Co.
Eric P. Mirabel JD LLM
Intellectual Property Attorney
Eric is a well-known IP attorney and author, specializing in high-tech patents including biotechnology, chemistry, electronics, and business methods involving softwares. His legal articles are cited by lawyers and by the courts, including the US Federal Circuit Court of Appeals. Formerly, Eric was the Head of IP for Tanox Inc and BioArray Solutions Ltd.